CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis Intravascular Ultrasound Guidance Reduces Cardiac Death and Coronary Revascularization in Patients Undergoing Drug-Eluting Stent Implantation: Results From a Meta-Analysis of 9 Randomized Trials and 4724 Patients Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options Intravascular ultrasound-guided implantation of drug-eluting stents to improve outcome: a meta-analysis Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents EXCELling in Left Main Intervention Precision Medicine in TAVR: How to Select the Right Device for the Right Patient

Clinical Trial2016 Jan 21;37(4):365-74.

JOURNAL:Eur Heart J. Article Link

Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial

Helft G, Steg PG, OPTImal DUAL Antiplatelet Therapy Trial Investigators. Keywords: DAPT duration; coronary artery disease; DES; platelet aggregation; inhibitors; stents; thrombosis

ABSTRACT